Assembly Biosciences (ASMB) EPS (Weighted Average and Diluted) (2019 - 2025)
Historic EPS (Weighted Average and Diluted) for Assembly Biosciences (ASMB) over the last 6 years, with Q3 2025 value amounting to -$0.72.
- Assembly Biosciences' EPS (Weighted Average and Diluted) rose 5231.79% to -$0.72 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.79, marking a year-over-year increase of 3078.03%. This contributed to the annual value of -$6.69 for FY2024, which is 4999.19% up from last year.
- Latest data reveals that Assembly Biosciences reported EPS (Weighted Average and Diluted) of -$0.72 as of Q3 2025, which was up 5231.79% from -$1.33 recorded in Q2 2025.
- In the past 5 years, Assembly Biosciences' EPS (Weighted Average and Diluted) ranged from a high of -$0.41 in Q3 2021 and a low of -$4.46 during Q1 2023
- In the last 4 years, Assembly Biosciences' EPS (Weighted Average and Diluted) had a median value of -$1.58 in 2024 and averaged -$1.84.
- In the last 5 years, Assembly Biosciences' EPS (Weighted Average and Diluted) plummeted by 38963.39% in 2021 and then surged by 6278.03% in 2024.
- Quarter analysis of 4 years shows Assembly Biosciences' EPS (Weighted Average and Diluted) stood at -$1.37 in 2021, then fell by 29.2% to -$1.77 in 2023, then rose by 2.76% to -$1.72 in 2024, then skyrocketed by 58.17% to -$0.72 in 2025.
- Its EPS (Weighted Average and Diluted) was -$0.72 in Q3 2025, compared to -$1.33 in Q2 2025 and -$1.17 in Q1 2025.